Overview and Thoughts on WHO International Drug Monitoring

doi:10.19803/j.1672-8629.2021.01.08

Abstract

Abstract: This article was intended to review the history of the World Health Organization (WHO) Programme for International Drug Monitoring and the WHO Collaborating Centres,and to introduce the work of Uppsala Monitoring Center (UMC),including data management and technical support,scientific research,and WHO Drug Global so as to provide reference for future cooperation.

Key words: WHO programme for international drug monitoring, drug safety monitoring, Uppsala monitoring center, WHO collaborating centres, adverse drug reaction

CLC Number:

FAN Rong, DONG Duo. Overview and Thoughts on WHO International Drug Monitoring[J]. Chinese Journal of Pharmacovigilance, 2021, 18(1): 43-46.

References

[1] WHO Basic documents:forty-ninth edition (including amendments adopted up to 31 May 2019)[R].to 31 May 2019)[R].Geneva:World Health Organization,2020.
[2] UMC.The story of UMC and the WHO programme[EB/OL].(2020-01-16)[2020-08-01].https://www.who-umc.org/global-pharmacovigilance/who-programme/the-story-of-umc-and-the-who-programme/.
[3] UMC.Members of the WHO Programme for International Drug Monitoring[EB/OL].(2020-06-22)[2020-08-01].https://www.who-umc.org/research-scientific-development/collaborations/previous-collaborations/.
[4] Yang Y.Research on the implementation of pharmacovigilance system in drug administration law and the application of ICH e2 guideline[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2020,17(2):65-71.
[5] WHO.Guide for WHO collaborating centres[EB/OL].(2018-01-01)[2020-08-01].http://www.who.int/collaborating centres/information/en/.
[6] WHO.WHO collaborating centres database &portal[DB/OL].(2020-08-01)[2020-08-01].http://apps.who.int/whocc/.
[7] WEB-RADR.First innovative medicines initiative WEB-RADR workshop:mobile technologies and social media as new tools in pharmacovigilance[EB/OL].(2015-01-05)[2020-08-01].https://web-radr.eu/2015/01/05/first-innovative-medicines-initiative-web-radr-workshop-mobile-technologies-and-social-media-as-new-tools-in-pharmacovigilance/.
[8] George Hripcsak,Jon D Duke,Nigam H Shah,et al.Observational health data sciences and informatics (OHDSI):opportunities for observational researchers[J].Stud Health Technol Inform,2015(216):574-578.
[9] UMC.Previous collaborations[EB/OL].(2017-09-26)[2020-08-01].https://www.who-umc.org/research-scientific-development/collab-orations/previous-collaborations/.
[10] UMC.WHODrug global Chinese[EB/OL].(2019-10-10)[2020-08-01].https://www.who-umc.org/whodrug/whodrug-portfolio/whodrug-global/whodrug-global-chinese/.
[11] UMC.What is WHO-ART?[EB/OL].(2017-12-14)[2020-08-01].https://www.who-umc.org/vigibase/services/learn-more-about-who-art/.
[12] UMC.International pharmacovigilance training course:Join us in Uppsala,Sweden,for our long-established annual pharmacovigilance course.[EB/OL].(2020-03-04)[2020-08-01].https://www.who-umc.org/education-training/educationtraining/international-pharma-covigilance-training-course/.
[13] UMC.ISoP-UMC training:The International Society of Pharmac-ovigilance (ISoP) andUMC collaborate in educational initiatives to strengthen pharmacovigilance in Asia and in Latin America.[EB/OL].(2020-01-07)[2020-08-01].https://www.who-umc.org/education-training/education-training/isop-umc-training/
[14] NMPA.The State Food and Drug Administration became a member of the International Technical Coordination Committee for Registration of Human Drugs[EB/OL].(2017-06)[2020-08-01].http://www.nmpa.gov.cn/WS04/CL2097/318606.html.
[15] NMPA.China's National Medical Products Administration was elected as a member of the Management Committee of the International Human Drug Registration Technical Coordination Committee[EB/OL].(2018-06)[2020-08-01].http://www.nmpa.gov.cn/WS04/CL2056/228304.html.
[16] Dong D,Liu W,Fan Y,et al.Brief analysis and enlightenment on 2018 annual report of eudravigilance[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2020,17(1):26-30.